HOME > BRAND

Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won

영문경제 / 2023-01-27 15:40:51
  • facebookfacebook
  • twittertwitter
  • kakaokakao
  • pinterestpinterest
  • navernaver
  • bandband
  • -
  • +
  • print
Samsung Biologics-2022 earnings

Samsung Biologics-2022 earnings

Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won

SEOUL, Jan. 27 (Yonhap) -- Samsung Biologics Co. on Friday reported its 2022 net income of 798.1 billion won (US$648.1 million), up 102.8 percent from a year earlier.

The company said in a regulatory filing that operating profit for the year rose 83.1 percent on-year to 983.6 billion won. Annual revenue increased 91.4 percent to 3 trillion won.

(END)

(C) Yonhap News Agency. All Rights Reserved

[관련기사]

Thom Browne to set up new company in Korea2023.01.28

LATEST ARTICLES

APEC spouse program

APEC spouse program